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1. Introduction 
Refers to myocardial, vascular, or electrophysiological dysfunction that is induced by the 
restoration of blood flow to previously ischemic tissue. Tissue damage caused when blood 
supply returns to the tissue after a period of ischemia. The absence of oxygen and nutrients 
from blood during the ischemic period creates a condition in which the restoration of 
circulation results in inflammation and oxidative damage through the induction of oxidative 
stress rather than restoration of normal function. 
Early reperfusion of ischemic myocardium is an accepted approach for the management of 
patients with acute coronary syndromes. In addition, surgical interventions requiring 
interruption of blood flow to the heart, out of necessity, must be followed by restoration of 
perfusion. Reperfusion, although essential for tissue and/or organ survival, is not without 
risk due to the extension of cell damage as a result of reperfusion itself. 
Since rupture of the plasma membrane is a prominent feature of necrosis and ischemia-
reperfusion injury and is a lethal event, it is worth considering what might lead to rupture 
of the plasma membrane. Rupture of the plasma membrane could be facilitated by calpain 
or some other protease cleavage of the cytoskeleton. Complete loss of ATP would also 
inhibit ion pumps, which would result in swelling perhaps rupturing the plasma 
membrane, particularly if the cytoskeleton has been weakened (Murphy & Steenbergen, 
2008).  
It is possible that a combination of protease activation with loss of ATP, ion dysregulation 
and cell swelling all conspire to rupture the plasma membrane. A rise in cytosolic free Ca2+ 
concentration [Ca2+]i has been consistently observed in ischemia and early reperfusion. A 
rise in [Ca2+]i will lead to activation of calpains, which could be involved in cleaving 
proteins leading to plasma membrane rupture. Calpain activates the proapoptotic BID, and 
also cleaves Atg5, shifting the balance from autophagy to apoptosis. An increase in [Ca2+]i 
and ROS can lead to activation of an inner mitochondrial large-conductance channel known 
as the Mitochondrial permeability transition (MPT). Opening of this channel would lead to 
loss of ATP and mitochondrial function, which would quickly lead to mitochondrial 
swelling and release of cytochrome c, which could activate apoptosis. If a large number of 
mitochondria in a cell undergo opening of the MPT, the cell will lose the capacity to make 
ATP, and the cell will lose ion homeostasis, resulting in cell swelling, membrane rupture, 
and cell death (Murphy & Steenbergen, 2008).  
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Platelet-dependent thrombus formation is a key event in the pathogenesis of acute 
myocardial infarction (AMI). Platelets mediate both thrombotic occlusion of the entire 
epicardial coronary artery and also accumulate in the microcirculation resulting in 
impairment of microcirculation and provoking myocardial ischemia during reperfusion 
(Gawaz, 2004).. 
Despite an improved understanding of the pathophysiology of this process and encouraging 
preclinical trials of multiple agents, most of the clinical trials to prevent reperfusion injury 
have been disappointing. Despite these problems, adjunctive therapies to limit reperfusion 
injury remain an active area of investigation. In these studies vitamin E has been tried to 
ameliorate lethal reperfusion injury. 
2. Protective effects of vitamin E against myocardial ischemia/reperfusion 
injury in rats 
Prevention of ischemia-reperfusion (I/R) injury is crucial for successful cardiac surgery. In 
cardiac surgery, it is reported that pharmacological agents can be administered prior to 
ischemia, enabling them to exert their protective effects on mitochondria prior to ischemia 
and reperfusion. The role of α-tocopherol (vitamin E) as a chain-breaking antioxidant is well 
characterized in vitro; it is considered the major lipophilic antioxidant in the human body, 
specifically by its reaction with peroxyl free radicals (Navarro et al., 2005). It has been 
demonstrated that vitamin E deficiency is responsible for increased myocardial injury 
caused by oxidative stress and that I/R of the heart is associated with a blunting in cardiac 
α-tocopherol levels (Altavilla et al., 2000). Vitamin E has been extensively assayed in 
experimental animal diseases, and in the protection and treatment of human diseases. 
Research provided evidence that vitamin E intake much higher than the current 
recommended dietary allowance could contribute to or improve human health. It has been 
reported that dietary requirements to prevent deficiency and maintain apparent health is 
substantially less than optimal amounts necessary to provide protection against 
degenerative conditions and chronic diseases. Results of a number of studies suggested that 
increased vitamin E intake is associated with decreased risk of coronary heart disease, and 
certain types of cancer as well as enhancement of immune function (Ricciarelli et al., 2002 ; 
Dong et al., 2009). Literatures concerning safety, and tolerance of oral vitamin E 
demonstrated that vitamin E is relatively nontoxic (Dong et al., 2009; Hanson et al., 2007). In 
a 91-day study of rats receiving up to 316-443 mg vitamin E/animal/day, vitamin E had no 
adverse effects on weight gain, food intake, organ weights, hematology or serum chemistry 
values (Krasavage et al., 1977). In the heart and cardiovascular system, nitric oxide (NO) 
plays a significant role. The specific roles of NO in the heart in general and on cardiac 
mitochondria in particular remain controversial. It has been reported that both endogenous 
and exogenous sources of NO exert important modulatory effects on mitochondrial function 
(Davidson & Duchen, 2006). Nitric oxide donors have been shown to induce a powerful 
cardioprotection against I/R injury in mice (Wang et al., 2005). However, literature 
reporting varying results of NO therapy, with some investigators reporting cardioprotective 
effects, whereas others report cardiotoxic effects ( Bell et al., 2003). Mitochondrial 
permeability transition (MPT) is a nonspecific pore in the inner mitochondrial membrane. It 
has been reported that the opening of the MPT converts the mitochondria from an organelle 
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that provides adenosine triphosphate to sustain heart function into an instrument of cell 
death by apoptosis if the insult is mild, and to necrosis if the insult is profound (Halestrap et 
al., 2004). It is hypothesized that a major component of I/R injury is necrotic cell death, 
which is widely thought to be the consequence of opening the MPT as reported by  previous 
literature (Costa et al., 2006). Functional recovery of the Langendorff-perfused heart from 
ischemia inversely correlates with the extent of the opening, and inhibition of the MPT 
provides protection against reperfusion injury (Halestrap et al., 2004). Previous literature 
(Kim et al., 2006) reported that radical oxygen species (ROS) generated during early 
reperfusion is the primary activator of the MPT, and cardiomyocyte death. Some recently 
developed, intracellularly targeted scavengers have been reported to provide some 
reduction in infarct size (Sheu et al., 2006). Antioxidants such as vitamins C, and E have also 
been suggested to scavenge ROS and reduce ischemic injury (Qin et al., 2006). A study, 
therefore, was performed with the following objectives, first, to determine whether a short 
course of oral administration of vitamin E in a megadose as compared to a NO donor 
nitroglycerin (GTN) can provide sufficient protection of the heart against reperfusion 
induced injury, and second, to determine whether a combined regimen of vitamin E and a 
NO donor confound superior protection to the hearts against this insult, and to investigate 
the effect of each of these pharmacological preconditioning agents on mitochondria and 
MPT. 
2.1 Methods  
This study was undertaken on  female Wistar rats weighing 150-200 gm. Rats were allocated 
into 4 groups: a- Control group, non-treated , b- GTN-treated group, rats received GTN 
intraperitoneal 25 minutes before sacrifice, in a dose of 120 μg/kg bw  (Zhou et al., 2002) ,c- 
Vit E-treated group, rat received vitamin E by oral tubal feeding 16-20 hours before sacrifice, 
in a dose of 250mg/rat d- Vit E and GTN-treated group, rats received vitamin E and GTN as 
in both GTN-treated group and vit E -treated group.  
Experimental procedures; On the day of the experiments, rats were weighed and injected 
intraperitoneally with heparin sodium, 1000 IU. One hour later, the rats were anesthetized 
with thiopental sodium 40 mg/kg intraperitoneally.  
In vitro studying of isolated hearts: Hearts were excised and perfused in a Langendorff 
preparation with the standard Krebs-Henselite Bicarbonate (KHB) buffer, pH 7.4 
equilibrated with O2:CO2 (95%:5%) at 37 º C (Ayobe &Tarazi, 1983). After 20 minutes 
stabilization period, baseline cardiac activities were recorded using isometric force 
transducer connected to a two-channel oscillograph. 
Ischemia Reperfusion Technique:: After recording baseline cardiac activity, 30 minutes of 
ischemia was induced by stopping the perfusing fluid, and at 30-minute reperfusion, the 
cardiac activity was recorded again. 
Cardiac activity was assessed by the following parameters: heart beating rate (BR), rate of 
tension development (dT/dt) and half relaxation time (1\2 RT). Myocardial flow rate (MFR) 
was measured at the same intervals by timed volumetric collection. Results were expressed 
as the percentage change of the measured parameters relative to baseline values to 
normalize individual differences between basal values among each group.  
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The cardiac chambers were weighed. The ventricles were used to isolate mitochondria. 
Mitochondria were isolated by conventional procedures of differential centrifugation. 
Hydrolysis of mitochondrial nicotinamide adenine dinucleotide (NAD +) directly reflects 
MPT opening. The NAD+ was measured after perchloric acid extraction (Di Lisa et al., 2001; 
Yamazaki et al., 2004). The malondialdehyde (MDA) was estimated in cardiac homogenates 
by the double heating method of Draper and Hadley (Draper & Hadley, 1990). Data for 
MDA and NAD+ was calculated by non-parametric Mann –Witney test.  
Electron microscopic study: Parts of the lower half of the left ventricle were fixed in 4% 
glutaraldehyde, dehydrated and embedded in resin. Sections of 60 nm thickness were cut on 
copper grids and stained with uranyl acetate followed by lead citrate for examination by the 
electron microscope  (Hunter, 1984).  
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Fig. 1. The malondialdehyde (MDA) and mitochondrial nicotinamide adenine dinucleotide   
(NAD +) levels after 30 minutes reperfusion in control rats, nitroglycerine-treated rats 
(GTN), vit E-treated rats and vit E & GTN-treated rats. Data are presented as means  SD   
P = 0.004 as compared to control rats. 
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Fig. 2. Showing irregular, disorted myofilaments. They appear loose and 
discontinuous.Mitochondiae are pleomorphic and idely spaced (controll group x60000). 
Arrow shows disruption in the mitochondrial membrate (x15000). 
 
 
Fig. 3. Myofilaments appear irregular but more dense. (NTG group x6000). Inset – 
mitochondriae show disrupted cristae and arrow shows discontinuous mitochondrial 
membrane (x15000). GTN group – group received nitroglycerin 
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Fig. 4. Showing regular dense and continuous myofilaments. (Vit E group x6000). Inset – 
mitochondriae are regular in shape. They reveal transverse, parallel cristae.Arrow shows 
continuous mitochondrial membrane. (x15000). Vit E group – received vitamin E. 
 
Fig. 5. Showing regular and dense myofilaments (GTN and Vit E group x6000.). Inset – 
mitochondriae are electron dense with unclear cristae. (x15000). GTN and Vit E group – 
received nitroglycerin and vitamin E. 
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Group 
(n=7) 
%BR %dT/dt %½RT %MFR 
Control -16.21±4.93 -23.75±6.88 22.85±9.84 -21.78±13.07 
GTN-tr. -21.16±11.04 22.94±20.64 46.43±19.57 -53.31±9.74 
Vit E-tr. 15.37±26.21 39.66±24.43a 10.71±12.02 -17.57±17.68b 
Vit E and 
GTN-tr. 
-15.10±7.11 38.48±23.67a 14.29±5.04 -25.44±4.24 
Data are presented as mean ± SEM. n: is the number of rats. a:Significance calculated by least significant 
difference (LSD) at P=0.03 from control group, b:Significance calculated by LSD at P=0.04 between vit E-
tr., and GTN-tr groups. BR - beating rate, dT/dt - rate of tension development, ½ RT -half relaxation 
time, MFR - myocardial flow rate.  
Table 1. Percentage changes from baseline values of cardiac activity at 30 minutes 
reperfusion after 30 minutes of ischemia (I/R) of perfused hearts isolated from; control rats, 
GTN-treated rats (GTN-tr.),vitamin E-treated rats (vitE-tr.), and vitamin E & nitroglycerin-
treated rats (vit E and  GTN-tr.). 
2.2 Effects of vitamin E versus nitroglycerine on I/R injury 
Our results demonstrated that a short course of vitamin E treatment induced preconditioning 
in the hearts. The vitamin E therapy, enhanced contractile, and vascular recovery, and 
attenuated oxidative stress in cardiac tissue, as demonstrated by the decrease of MDA in 
cardiac tissue. Moreover, this therapy protected the hearts against MPT opening as indicated 
by significant increase of NAD+ in cardiac tissue. Histological examination showed less 
mitochondrial injury induced by reperfusion in the hearts of this group, with preservation of 
the myocytes structure. Moreover, the present study clearly demonstrated that preischemic 
treatment with GTN; a NO donor did not provide significant protection of hearts against I/R-
induced contractile dysfunction and tissue injury. Peroxynitrite (ONOO–), the reacting product 
of NO and O2–, is apotent cytotoxic agent. It is highly reactive with a wide variety of 
molecules, including deoxyribose, cellular lipids, and protein sulfhydryls, and results in 
oxidative tissue damage (Farshid et al., 2002). In this study, GTN treatment did not attenuate 
the reperfusion-mediated increase of MDA in cardiac tissues of GTN-treated rats. This finding 
suggested that ONOO– might be formed excessively in post-ischemic myocardial tissue. In the 
current study, supplementation of NO donor could have raised cardiac tissue NO 
concentration, with the coincident increase in free radical generation at reperfusion established 
the conditions of ONOO– formation. Therefore, we suggest that exogenous NO failed to 
provide cardioprotection, due to concomitant increase of ONOO–. In this study, the non 
significant increase of NAD+ content in isolated hearts from GTN-supplemented rats indicated 
failure of GTN to attenuate MPT opening. The opening of that channel lead to mitochondrial 
swelling, release of apoptotic molecules and eventually cell death. This suggestion was further 
confirmed by histological examination of isolated hearts from GTN-supplemented rats. 
Previous literature (Dhalla et al., 2000) reported a depletion of endogenous antioxidants in the 
ischemic hearts upon reperfusion. Various studies have reported the beneficial effects of 
antioxidants as these agents render resistance to the hearts against I/R injury. However, other 
investigators have failed to observe such results. The slow incorporation of vitamin E into 
tissues, due to its marked lipophilicity, is probably responsible for its failure as a 
cardioprotective compound as shown during the acute administration of α-tocopherol after 
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I/R injury induced in the pig (Altavilla et al., 2000). Several studies reinforce the importance of 
localization and timing in cardioprotection. Delivery of the antioxidants to the right 
compartment in the right time period is very difficult to achieve in controlled animal studies, 
and even more difficult in patients. As a result of the controversy in the animal studies, and 
the failed clinical trials, it is often concluded that inhibition of ROS will not influence infarct 
size. A more realistic assessment is that to have a significant benefit in reducing infarct size 
requires the correct delivery of mitochondrial targeted antioxidants perhaps in conjunction 
with other therapies. So in this study, we tried to give the animals vitamin E in a large dose, 
with a sufficient time to provide its effects. The demonstration that prior exposure to a low 
concentration of H2O2 protects against MPT opening may be of pathophysiological importance 
for cardioprotection (Costa et al., 2006). By the same reasoning, in preconditioning, we 
speculate the need for an antioxidant that attenuates the large burst of oxidative stress at the 
start of reperfusion without completely neutralizing free radicals. 
We suggest that vitamin E as a physiological antioxidant acted to scavenge free radicals 
without completely neutralizing them, thereby affording a significant preconditioning 
effect. Reduction of free radical formation inhibits MPT opening, thereby affording 
preconditioning. This is clearly demonstrated in the current study, since there was a 
significant increase of NAD+ content of reperfused hearts in the vitamin E-treated groups. 
Histological examination confirmed this result, as it revealed marked protection of the 
normal structure of myocytes and mitochondria. Addition of GTN treatment to vitamin E 
attenuated its cardioprotective effect. In summary, the findings of the present study provide 
evidence that a short course of vitamin E treatment protected the heart against reperfusion-
injury compared to a NO donor. The MPT is an important target of this protection.  
3. Effects of vitamin E treatment on age-associated changes in cardiac 
responses to the injury of post I/R 
Aging is one of the most important risk factors for the development of cardiovascular 
disease. Aging is characterized by loss of myocytes, remodeling and impaired contractile 
function in the heart. The rate of programmed cell death in the left ventricle increases with 
age (Kwak et al., 2006). Meanwhile the aged heart faces a high risk of free radical injury 
owing to slow generation of antioxidant enzymes by its cells, and a general decline in this 
system may be another reason for the development of myocardial dysfunction (Asha Devi et 
al.,  2003 a ). 
It is well established that nitric oxide (NO), is constitutively generated within the heart, not 
only by the endothelium but also by the myocytes (Balligand et al., 1995). Numerous 
previous animal studies have reported that there is a loss of NO biological activity and /or 
biosynthesis during aging (Matz et al., 2000). 
Oxygen free radicals increase in concentration upon reperfusion of ischemic cardiac tissue 
(Xia et al., 1996). It is well established that these reactive species can interact with and 
damage various cellular components (Berlett & Stadtman, 1997). Free radical production in 
the heart has also been reported to increase with age (Sohal et al., 1990). Thus, although 
restoration of blood flow is the sole method for salvaging ischemic tissue, oxidative damage 
may occur during reoxygenation and contribute to ischemia–reperfusion injury.  
Regular exercise is a key component of cardiovascular risk prevention strategies. Physical 
activity is known to cause generation of free radicals. Exercise training in old animals failed 
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to enhance antioxidant activity (Hatao et al., 2006). However swim training especially at 
low-intensity, was found to be beneficial as a major protective adaptation against oxidative 
stress particularly in the older myocardium (Kiran et al., 2004). The tocopherols (major 
vitamers of vitamin E) are believed to play a role in the prevention of human aging-related 
changes, and are of particular interest, mainly because of their antioxidative properties 
(Asha Devi   et al., 2003 b).  
From the aforementioned data, it seems possible that free radical - mediated injury is a 
major issue in the increase of aging related reperfusion-induced myocardial dysfunction. 
Exercise training program could not always protect the aging heart satisfactorily. We tried 
to test the hypothesis that using an antioxidant as vitamin E could lead to better protection 
of the aging hearts as compared with exercise training.  
Therefore, a study was conducted to compare the effects of vitamin E treatment versus 
swim- exercise training on age- associated changes in cardiac responses to the injury of post 
I/R.  
3.1 Methods 
This work was undertaken on female Wistar rats aged 16-18 months. Rats were allocated 
into 3 groups: a) Control group of aged rats, b) Exercise -trained aged rats subjected to daily 
physical exercise by swimming in the water tank, for 2 hours daily, 6 days aweek for 2 
weeks, and c) Vitamin E-treated aged rats subjected to daily injection of vitamin E (300 
mg/kg) intraperitoneally, 6 days aweek for 2 weeks.  
The swim-training program adopted was according to Refaat et al., (1989), in a swimming 
tank, filled with water and maintained at thermoneutral temperature of 30°c. A motor fan in 
the tank stirs strong water currents. This ensures uniformity of temperature and forces the 
rats to swim actively all the time. 
3.1.1 Experimental procedures 
They were done as previously described (Ayobe &Tarazi, 1983). Peak developed tension  per 
left ventricular weight as well as coronary flow rate per left ventricular weight were calculated 
relative to left ventricular weight (PT/LV,  g /100mg)& (CF/LV, ml /100mg/min). 
Nitrate concentration in coronary effluents, as a stable product of nitric oxide (NO), was 
measured by an endpoint one-step enzymatic assay using nitrate reductase, as described by 
Bories and Bories, (1995), and modified in tissues by Kassim, (1997).  
3.1.2 Effects of exercise on cardiac weights and post Ischemia-reperfusion (I/R) 
responses 
In this study, exercise was found to exert a trophic effect on cardiac chambers manifested by 
significant increase of the absolute & relative weights of atria, right ventricle, and left 
ventricle. Swimming is well recognized for its effectiveness in inducing myocardial 
hypertrophy (Evangelista et al., 2003). Exercise can protect cardiac function of the aging 
heart by protection against; loss of cardiac myocytes, reduction in number of myonuclei, 
reactive hypertrophy of remaining myocytes, and increased connective tissue in left 
ventricle (LV) of the aging rat heart. This protection is achieved through attenuation of age-
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induced elevation in Bax/Bcl-2 ratio, thereby inhibits apoptosis (Asha Devi et al., 2003a), 
and exerts its trophic effect.  
Although exercise-trained rats had significant increase in LV and LV/BW that indicates LV 
hypertrophy, they showed Peak developed tension similar to control which could be 
attributed to the increase of free radical in aged rats induced by exercise. Oxygen free 
radicals are known to have deleterious effects on contractile force of heart (Gao et al., 1996).  
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Fig. 6. Mean values± SEM of: absolute weights (mg) of atria (AT), right ventricle (RV), left 
ventricle (LV), and their relative weights (mg/g) (AT/BW), (RV/BW), (LV/BW) in control 
rats       , exercise-trained rats       , and vit. E-treated rats      .      
a. Significance calculated by least significant difference (LSD) at P < 0.05 from control 
group. 
b. Significance calculated by LSD at P < 0.05 between vit E-treated, and exercise-trained 
groups 
The results of ischemia-reperfusion of isolated hearts from both control and exercise-trained 
aged rats have shown the lack of tolerance to ischemia-reperfusion injury as regard 
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inotropic activities as well as myocardial flow rate. This could be explained in view of the 
increase in free radicals generation induced by exercise, even if small, was added to the 
increased free radicals generation induced by aging exceeding the antioxidant defense 
capacity of the heart leading to loss of beneficial cardio-protective effect of exercise on 
ischemia-reperfusion injury (Hatao et al., 2006).  
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Fig. 7. Mean absolute and percent values ± SEM of: heart beating rate(HR), Peak developed 
tension(PT), Peak developed tension per left ventricular weight(PT/LV), Time to peak 
tension (TPT), Half relaxation time(½ RT), and Coronary flow rate per left ventricular 
weight (CF/LV), at 30 minutes reperfusion of hearts isolated from control rats        , exercise- 
trained rats       , and vit. E- treated rats       .       
a. Significance calculated by least significant difference (LSD) at P < 0.05 from control 
group. 
b. Significance calculated by LSD at P < 0.05 between vit E-treated, and exercise-trained 
groups 
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The increased free radicals generation such as superoxide anion could react with NO to 
form peroxynitrate, decreasing NO biological activity. Peroxynitrate molecule by itself 
might play a significant role in oxidative tissue damage. This is supported in this study by 
the absence of increase of nitrates in the coronary effluent from exercise- trained aged rats at 
30 min reperfusion.  
 
Fig. 8. Mean values ±SEM of nitrates in coronary effluents (nmol/100mg LV/min) at 
baseline values, and 30 minutes of reperfusion in control rats       , exercise-trained rats      , 
and vit. E-treated rats      .  
a. Significance calculated by least significant difference (LSD) at P < 0.05 from control 
group. 
b. Significance calculated by LSD at P < 0.05 between vit E-treated, and exercise-trained 
groups 
Also, the heart beating rate of the exercise-trained rats could not be preserved after 30 min 
of reperfusion. This could be attributed to the increased free oxygen radicals in these rats, 
since oxyradicals have been implicated as a possible cause of reperfusion arrhythmias 
(Tanguy et al., 1998). However, the rate of relaxation of hearts excised from exercise-trained 
rats showed better tolerance to I/R after initial intolerance, and such improvement is in 
accordance to a recent report by Libonati et al., (2005), who found that sprint training in rats 
improves post-ischemic left ventricular diastolic stiffness due to up-regulation of 
myocardial glycolysis, with ATP production that protects the heart from ischemia-
reperfusion as it plays an important role in actin-myosin rigor bond dissociation, and 
regulating myocardial diastolic function. 
Effects of vitamin E on cardiac weights and Post Ischemia-Reperfusion (I/R) responses: 
Vitamin E has been reported to stimulate upregulation at the expression level of B cl-2 
gene, B cl-2 molecule is involved in the inhibition of apoptosis (Azzi et al., 2004). 
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Therefore, vitamin E by preventing apoptosis of myocardial cells could be expected to 
induce hypertrophy of the heart (trophic effect). However in case of vitamin E–treated 
rats, results have shown that the effect of vitamin E on the rate of growth of right and left 
ventricles was not similar. While the rate of growth of right ventricle was increased by the 
anti-apoptosis effects of vitamin E. The increase in left ventricle & left ventricle/ body 
weight was insignificant. This could be attributed to the favorable effects of vitamin E on 
reduction of blood pressure and blood viscosity (Costa et al., 2005). These two factors 
have been claimed to induce growth of left ventricle during aging (Ghali et al., 1997). 
Thereby, by eliminating these two factors, the rate of growth of left ventricle was 
decreased under the influence of vitamin E supplementation counteracting its trophic 
effect in aged rats.  
In contrast to aged control rats and exercise-trained aged rats, the isolated hearts from 
vitamin E-treated rats showed better tolerance as regard inotropic activity, especially force 
generation measured as peak developed tension as well as coronary flow rate. In 
accordance, Venditti et al., (1999) showed a protective action of vitamin E treatment against 
lipid peroxidation and cardiac dysfunction associated with ischemia- reperfusion in rats. 
Vitamin E decreases free radical deleterious effect on cell membrane, proteins, DNA, and 
decreases both ROS mediated direct ischemia-reperfusion mediated injury, as well as 
peroxynitrite-mediated injury and thereby preserving NO through preventing its 
inactivation by its transformation to peroxynitrite (Kamat, 2006). In support, this study 
showed significant increase of nitrates in coronary effluent from vitamin E- treated aged rats 
measured at 30 min of reperfusion.  
In view of the aforementioned data, vitamin E proved to be a cardio-protective agent as it 
attenuated the injury of post ischemia-reperfusion on the aged myocardium. This beneficial 
effect of vitamin E could be partially attributable to preservation of NO biological activity by 
preventing its transformation to the toxic compound peroxynitrite. 
On the other hand, the swim-training program adopted in this study, as regard tolerance to 
ischemia-reperfusion apart from improvement of half relaxation time, the swim-training 
program did not show other promising cardio-protective effects against cardiac changes 
associated with the aging process. 
Therefore, vitamin E supplementation could be recommended to aged people especially 
patients suffering from ischemic heart disease. Vitamin E could be used either alone or in 
combination with exercise training taking into consideration the duration and intensity of 
exercise program. 
Vitamin E and platelet function 
Platelets play a critical role in the pathophysiology of reperfusion (Gawaz, 2004). Platelet 
function is not static during ischemia-reperfusion. Instead, during ischemia regional platelet 
aggregability is increased. Systemic and regional platelet aggregability also increases during 
myocardial reperfusion. The mechanism of these responses is unknown but may be related 
to regional endothelial dysfunction created by ischemia. The response observed could also 
be explained by the release of proaggregatory mediators in the coronary and/or systemic 
circulation during ischemia-reperfusion (Gurbel et al., 1995).  
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Reperfusion induces an important inflammatory response, characterized by a massive 
production of free radicals and by the activation of the complement and leucocyte 
neutrophils (Gourdin et al., 2009). Platelets and neutrophils act synergistically in provoking 
postreperfusion cardiac dysfunction (Lefer et al., 1998). Activated platelets play an 
important role in the process of myocardial ischemia-reperfusion injury, and platelet-
derived P-selectin is a critical mediator (Xu et al., 2006), whereas platelet P-selectin promotes 
platelet interactions with leukocytes. Because platelets release potent proinflammatory 
chemokines and modulate leukocyte function, platelet accumulation in the postischemic 
microvasculature might significantly contribute to the manifestation of I/R injury (Massberg 
et al., 1998). 
Reperfusion of the tissue, subsequent to ischemia, results in burst of oxygen consumption 
with consequent generation of oxygen derived free radicals; the oxidant-anti oxidant status 
of the tissue is thrown out of balance and multi dimensional free radical mediated damage 
ensues. Since vitamin E is a potent natural anti-oxidant, its administration is expected to 
restore the imbalance. 
Effect of administration of 600 mg vitamin E each day, for six days, was observed on activity 
of some of the anti-oxidant enzymes and levels of malondialdehyde (as an index of free 
radical mediated damage) in the platelets of patients reperfused after myocardial infarction. 
It has been found that vitamin E administration significantly lowers the level of 
malondialdehyde in the patients. Vitamin E administration increases the activities of anti 
oxidant enzymes (superoxide dismutase, glutathione reductase and catalase) tested both in 
the patients and healthy controls. However, lowering of lipid peroxidation upon 
administration of vitamin E is specific for patients. These findings exhibit beneficial role of 
vitamin E administration in the management of the patients reperfused after myocardial 
infarction (Dwivedi et al., 2005). 
The results of Chen et al, (2002) suggested that the reduction of myocardial I/R injury with 
vitamin E supplementation may be the result of the inhibition of polymorphonuclear 
neutrophil (PMN) CD11b expression.  
Vitamin E supplementation in healthy subjects or patients with hypercholesterolemia was 
shown to diminish platelet function as assessed by ex vivo platelet aggregation of 11- 
dehydrothromboxane B2, a marker of in vivo platelet activation (Calzada et al., 1997; Davi et 
al., 1997). Celestini et al., (2002) demonstrated that vitamin E can potentiate the antiplatelet 
activity of aspirin by inhibiting the early events of platelet activation pathway induced by 
collagen. 
A study from our laboratory was to examine the possibility that vitamin E administration 
could exert an effect on blood elements and platelet aggregation. 
Materials and Methods  
Albino rats of both sexes weighing 180- 220 gm fed on a standard rat diet and fasted for 18- 
24 hours before sacrifice were used in this study. 
In vivo study: A total of 30 rats were used in this study. They were divided in two groups. 
Group I: Saline control group; rats in this group were injected with saline instead of vitamin 
E, daily for 5 consecutive days. Group II: vitamin E treated group; rats were injected with 
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vitamin E (300 mg/kg b.w.) intraperitoneally for five consecutive days. After 5 days all 
injections were stopped for 2 days. By the seventh day rats were anesthetized with 
pentobarbitone in a dose of 40 mg/kg b.w. 
Collection of blood samples: blood samples were obtained by arterial puncture from the 
abdominal aorta. One ml samples were collected into tubes containing EDTA for 
examination of RBCs and platelet counts, hemoglobin content and hematocrite values. 
Another blood samples were collected in chilled plastic tubes containing sodium citrate 
3.8gm/100 ml (9 volumes of blood to 1 volume of sodium citrate) and gently shaken. These 
blood samples were used for study of platelet aggregation. The citrated blood was 
centrifuged at 1500 r.p.m. for 5 min. The supernatant platelet rich plasma (PRP) was 
pipetted into clean plastic tubes. The remaining blood sample was centrifuged at 10,000 
r.p.m. for 10 min. to prepare platelet poor plasma (PPP). Standard PRP: the number of 
platelets in PRP was counted using coulter T-660 counter. The platelet number was adjusted 
to a standardized number of 3 x 105 platelet per µl by dilution with autologus platelet poor 
plasma. 
Aggregation study: platelet aggregation was performed using Chrono-Log automatic 
aggregometer (model 540-VC, Chrono-Log Corp, Harvertown, USA) coupled with 
computer and printer. ADP as an aggregating agent was used at a final concentration of 10 
uM. The maximum aggregation was recorded after 3 min. 
In vitro of vitamin E on platelet aggregation 
Collection of blood samples: blood was collected from normal rats, anaesthetized by 
pentobarbitone, by arterial puncture from abdominal aorta into chilled tubes containing 
sodium citrate 3.8 gm%. Preparation of standard PRP was carried out as described in the in 
vivo experiments. 
The in vitro effect of vitamin E on ADP- induced platelet aggregation was studied by 
exposing PRP to rising concentrations of the vitamin 1,2,3,4 and 5 mg/ml. Equal volumes of 
saline were added to control samples. 
Aggregation study: was carried as described above in vivo experiments. 
Statistical analysis of the data was done using Student's "t" test for unpaired data according to 
Fisher and Yates (1957) P  0.05 was considered significant. 
Regression study: linear regression analysis was used to relate different parameters to a 
certain outcome (platelet aggregation) to find out the highest beta coefficient and the most 
important factor affecting this outcome. This analysis was performed on SPSS windows 
version eight. 
Results 
Table 1 portrays the results of in vivo effects of vitamin E on hematological parameters. 
RBCs count, Hb content and PCV showed slight and insignificant changes in vitamin E 
treated rats compared to their saline controls. The number of platelets was insignificantly 
decreased in vitamin E treated animals. However platelet aggregation induced by ADP 
showed a significant decrease (P  0.05) in this group (table 2 and figure 9).  
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Regression analysis: as seen in fig. 10, multiple regression analysis of platelet aggregation 
against other parameters. Only a significant negative correlation between platelet number 
and platelet aggregation was seen in vitamin E treated group (P  0.03). 
In vitro effect of vitamin E on platelet aggregation: the platelet aggregation effect of ADP in 
presence of rising concentration of vitamin E showed significant inhibition (P 0.01) only 
when vitamin E was added at a final concentration of 5 mg/ml. Addition of vitamin E in 
smaller concentrations of 2- 4 mg/ml final concentration produced insignificant inhibition of 
platelet aggregation. Almost no effect was seen when vitamin E was added at a final 
concentration of 1 mg/ml (table 3 and figure 11). 
 
RBCs 
x 106/ul 
Hb 
gm/dl 
PCV 
% 
Platelet 
count 
x 103/ul 
Platelet 
aggregation 
% 
Saline control 
(15) 
6.54±0.3 12.24±0.5 36.15±1.2 1146±71.12 68.1±1.9 
Vitamin E treated 
rats 
(15) 
6.33±0.2 11.93±0.3 35.3±0.9 1068±53.1 58.9±4 
P NS NS NS NS  0.05 
Data are mean± SEM In parenthesis is the number of observations   NS: non significant 
Table 2. Red blood cell count (RBCs), hemoglobin level (Hb), packed cell volume (PCV), 
platelet count and platelet aggregation in saline control and vitamin E treated rats. 
Additions to normal PRP 
 Final concentration of vitamin E 
Saline control 
 
1mg/ml 2mg/ml 3mg/ml 4mg/ml 5mg/ml 
(12) (8) (9) (11) (11) (13) 
50.08±2.6 50.75±2 47.1±2.32 44.36±2.85 44.7±3.4 37.23±3 
P NS NS NS NS  0.01 
Data are mean± SEM In parenthesis is the number of observations NS: non significant 
Table 3. In vitro effect of vitamin E on platelet aggregation of normal rat PRP in presence of 
different concentrations of vitamin E compared to saline control 
Parameters 
Group 
treatment  
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ADP-induced platelet aggregation%  
Fig. 9. Tracing of ADP- induced platelet aggregation of Vitamin E-treated rats (B) compared 
to saline treated rats (A). 
 
 
Vitamin E- treated rats    
Saline- treated rats    
Fig. 10. Correlation between platelet aggregation and platelet count among vitamin E-
treated rats and saline treated rats (by multiple regression analysis) 
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Fig. 11. Tracing of ADP- induced platelet aggregation of normal rats PRP in presence of 
vitamin E in concentrations of 1, 2, 3, 4 and 5 mg/ml respectively (B- F) compared to saline 
control (A) 
The data reported here demonstrated that administration  of megadose of vitamin E (300 
mg/kg for one week) to rats, produced slight and nonsignificant changes in red blood cell 
counts, hemoglobin content, packed cell volume. Platelet counts showed an insignificant 
decrease. However, the platelet aggregation responses to ADP of PRP from treated rats were 
significantly inhibited. This finding shows the safety of vitamin E in this supra-physiological 
dose of 300 mg/kg on blood parameters tested. 
On addition of vitamin E to normal PRP in vitro, the platelet aggregating effect of ADP 
showed significant inhibition only when vitamin E was added at a final concentration of 5 
mg/ml. Addition of vitamin E in smaller concentrations of 2- 4 mg/ml produced 
insignificant inhibition of platelet aggregation. Almost no effect was seen when vitamin E 
was added at a final concentration of 1 mg/ml. 
From these data, it can be concluded that this supra physiological dose of vitamin E is safe 
concerning the blood parameters tested.  
The observation in the present study that vitamin E when added in vitro to normal rat 
PRP caused significant inhibition of platelet aggregation in response to ADP; illustrate 
that vitamin E by itself exerts a direct antiplatelet effect. Higashi & Kikuchi (1974) were 
the first to demonstrate that vitamin E inhibits the aggregation of platelets using 
hydrogen peroxide as the aggregating stimulus. Subsequent studies by Steiner & 
Anastasi, (1976) demonstrated that vitamin E also inhibited platelet aggregation response 
to epinephrine, collagen and ATP. Moreover, Freedman and Keaney, (2001) found that 
platelet incorporation of vitamin E both in vitro and in vivo leads to dose-dependent 
inhibition of platelet aggregation in response to agonists such as arachidonic acid and 
phorbol ester.  
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Although it is best known for its antioxidant activity the exact mechanism of the antiplatelet 
effect of vitamin E is not exactly known and one of the following mechanisms may operate. 
First, it can be attributed to altered metabolism of prostaglandins. The vascular generation 
of prostacyclin (PGI2) is higher and the platelet thromboxane A2 generation is lower than 
normal. This view is supported by the findings of Steiner and Anastasi (1976) and others 
(Karpen et al., 1981; Pritchard et al., 1982; Pignatelli et al., 1999) that vitamin E inhibits 
platelet thromboxane A2 synthesis. On the other hand, PGI2 synthesis is stimulated possibly 
by reduction of cellular peroxide level (Gilbert et al., 1983). Second, the inhibition of platelet 
aggregation can be explained by the ability of vitamin E to inhibit intracellular mobilization 
of sequestrated calcium from the dense tubular system of the cytoplasm (Srivastava, 1986). 
Third, by its membrane stabilizing action, vitamin E would impair platelet release reaction. 
This view is supported observations of Feki et al., (2001) that vitamin E by its antioxidant 
effect, protects molecules and tissue against the deleterious effect of free radicals and also 
contributes to the stabilization of biological membranes. Fourth, unrelated to its antioxidant 
action, vitamin E was shown to inhibit protein kinase C (PKC) in various cell types with 
consequent inhibition of platelet aggregation (Azzi et al., 2002; Freedman et al., 1996; 
Freedman and Keaney, 2001). Further, vitamin E includes inhibitory effects are the result of 
specific interactions with component of the cell e.g. proteins, enzymes and membranes 
(Ricciarelli et al., 2002). 
Vitamin E attenuated P-selectin expression on activated human platelets and thus inhibited 
the P-selectin–dependent function, platelet–mononuclear cell (MNC) interaction. The 
mechanism probably was related to the inhibition of PKC activity in platelets. Since P-
selectin is an important atherothrombogenic adhesion molecule, this finding will provide us 
new insights into the mechanism by which dietary vitamin E inhibits thrombosis and 
atherogenesis and thereby reduces the risk of coronary artery diseases (Murohara et al, 
2004).  
Although these studies from our laboratory have shown that vitamin E administered in 
megadose, could provide a protective effect against the cardiac responses to the injury of 
post I/R. Further studies should be conducted to test the possibility of using vitamin E in 
cardiac surgery. 
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